VBY-891
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VBY-891, covering 2013-12-31 to 2013-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1) [Phase 1]